This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Humana Gains on Strong Membership Base and Sound Cash Reserves
by Zacks Equity Research
HUM benefits from a cost-effective health plan suite, continued expansion endeavors and a strong 2025 business outlook.
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
UnitedHealth Group (UNH) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $516.04, marking a +0.06% move from the previous day.
UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) concluded the recent trading session at $515.72, signifying a -0.48% move from its prior day's close.
UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw UnitedHealth Group (UNH) settling at $516.85, representing a +1.09% change from its previous close.
UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments
by Zacks Equity Research
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
Should You Invest in UnitedHealth (UNH) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag?
by Kaibalya Pravo Dey
UNH is making significant investments in AI and digital tools to enhance consumer experiences and streamline healthcare processes.
UnitedHealth Group (UNH) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $503.80, marking a +0.96% move from the previous day.
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
by Kaibalya Pravo Dey
With a strengthening commercial business, ELV is seeing steady membership growth.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $486.04, marking a +1.21% move from the previous day.
The Zacks Analyst Blog UnitedHealth, SAP, Toyota and Better Choice
by Zacks Equity Research
UnitedHealth, SAP, Toyota and Better Choice are included in this Analyst Blog.
Top Analyst Reports for UnitedHealth, SAP & Toyota Motor
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc. (UNH), SAP SE (SAP) and Toyota Motor Corp. (TM), as well as a micro-cap stock Better Choice Company Inc. (BTTR).
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
UnitedHealth Group (UNH) Stock Moves -1.67%: What You Should Know
by Zacks Equity Research
In the most recent trading session, UnitedHealth Group (UNH) closed at $467.05, indicating a -1.67% shift from the previous trading day.
Brookdale Incurs Loss in Q4 Due to Higher Costs, Shares Up 6%
by Zacks Equity Research
BKD's Q4 results reflect escalating general and administrative costs, partly offset by improved occupancy rates. It projects 2025 adjusted EBITDA within $430-$445 million.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $461.52 in the latest trading session, marking a -1.05% move from the prior day.
Markets Await Consumer Sentiment Data
by Zacks Equity Research
Markets Await Consumer Sentiment Data
Pre-Market Dow Sinks on UNH Report; Econ Reports After the Open
by Mark Vickery
The DOJ is bringing a civil case against UnitedHealthcare (UNH) -- the largest healthcare company in the world.
UnitedHealth Group (UNH) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $502.42, denoting a -1.69% change from the preceding trading day.
UnitedHealth Pulls Back 11% in 3 Months: Think Twice Before Buying
by Kaibalya Pravo Dey
While UNH is pushing for a more efficient and cost-effective healthcare system, ongoing regulatory uncertainty and mounting cost pressures could keep the stock under check.